| Literature DB >> 31627376 |
Jacquelyn L Meyers1, David B Chorlian2, Emma C Johnson3, Ashwini K Pandey4, Chella Kamarajan5, Jessica E Salvatore6,7, Fazil Aliev8, Stacey Subbie-Saenz de Viteri9, Jian Zhang10, Michael Chao11, Manav Kapoor12, Victor Hesselbrock13, John Kramer14, Samuel Kuperman15, John Nurnberger16, Jay Tischfield17, Alison Goate18,19, Tatiana Foroud20, Danielle M Dick21, Howard J Edenberg22,23, Arpana Agrawal24, Bernice Porjesz25.
Abstract
Differences in the connectivity of large-scale functional brain networks among individuals with alcohol use disorders (AUD), as well as those at risk for AUD, point to dysfunctional neural communication and related cognitive impairments. In this study, we examined how polygenic risk scores (PRS), derived from a recent GWAS of DSM-IV Alcohol Dependence (AD) conducted by the Psychiatric Genomics Consortium, relate to longitudinal measures of interhemispheric and intrahemispheric EEG connectivity (alpha, theta, and beta frequencies) in adolescent and young adult offspring from the Collaborative Study on the Genetics of Alcoholism (COGA) assessed between ages 12 and 31. Our findings indicate that AD PRS (p-threshold < 0.001) was associated with increased fronto-central, tempo-parietal, centro-parietal, and parietal-occipital interhemispheric theta and alpha connectivity in males only from ages 18-31 (beta coefficients ranged from 0.02-0.06, p-values ranged from 10-6-10-12), but not in females. Individuals with higher AD PRS also demonstrated more performance deficits on neuropsychological tasks (Tower of London task, visual span test) as well as increased risk for lifetime DSM-5 alcohol and opioid use disorders. We conclude that measures of neural connectivity, together with neurocognitive performance and substance use behavior, can be used to further understanding of how genetic risk variants from large GWAS of AUD may influence brain function. In addition, these data indicate the importance of examining sex and developmental effects, which otherwise may be masked. Understanding of neural mechanisms linking genetic variants emerging from GWAS to risk for AUD throughout development may help to identify specific points when neurocognitive prevention and intervention efforts may be most effective.Entities:
Keywords: AD; AUD; EEG coherence; PRS; developmental trajectories; neural connectivity; sex differences
Year: 2019 PMID: 31627376 PMCID: PMC6826735 DOI: 10.3390/brainsci9100280
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Schematic of the bipolar electrode pairs (connected with dotted lines) and coherence pairs (connected with solid lines) derived between bipolar electrode pairs. Frontal-central sagittal coherence pairs are represented in blue; (1) F8-T8–F7-T7, (2) F4-C4–F3-C3, (3) F3-C3–F8-T8, (4) F4-C4–F7-T7, (5) F3-C3–F7-T7, (6) F4-C4–F8-T8, (7) FZ-CZ–F7-T7, (8) FZ-CZ–F3-C3, (9) FZ-CZ–F8-T8, (10) FZ-CZ–F4-C4. Central-parietal sagittal coherence pairs are represented in red; (11) T8-P8–T7-P7, (12) C4-P4–C3-P3, (13) C3-P3–T8-P8, (14) C4-P4–T7-P7, (15) C3-P3–T7-P7, (16) C4-P4–T8-P8, (17) T7-P7–CZ-PZ, (18) C3-P3–CZ-PZ, (19) T8-P8–CZ-PZ, (20) C4-P4–CZ-PZ. Parietal-occipital sagittal coherence pairs are represented in purple; (21) P4-O2–P3-O1. Intra-hemispheric lateral coherence pairs are represented in orange; (22) T7-C3–F7-F3, (23) P7-P3–F7-F3, (24) P7-P3–T7-C3, (25) T8-C4–F8-F4, (26) P8-P4–F8-F4, (27) P8-P4–T8-C4.
Descriptive characteristics in the analytic sample.
| Prospective Study EEG Subsample of European Ancestry | |
|---|---|
| Genotyped ( | 1426 |
| Female (%) | 51.6% |
| Mean Age (SD) | 17.7 (7.4) |
| Self-reported as ‘White’ (%) | 98.1% |
| Self-reported as ‘Black’ (%) | 0.1 |
| Self-reported as ‘Latin/Hispanic’ (%) | 0.1 |
| Self-reported as ‘Other’ (%) | 4.4 |
| Family History of AUD (%) | 41.1 |
| Ever Drinkers (%) | 71.8 |
| DSM-5 AUD (%) | 35.4 |
| DSM-5 Cannabis Use Disorder, lifetime (%) | 23.4 |
| DSM-5 Cocaine Use Disorder, lifetime (%) | 4.2 |
| DSM-5 Opioid Use Disorder, lifetime (%) | 5.3 |
First quartile of association beta coefficients and p-values of AD PRS (p-threshold < 0.001) with low theta and high alpha EEG coherence in males ages 12–31 with −log10 transformation. All values in bold meet the false discovery rate criterion of 10−4.
| Ages 12–17 | Ages 18–25 | Ages 26–31 | |||||
|---|---|---|---|---|---|---|---|
| Low theta | High alpha | Low theta | High alpha | Low theta | High alpha | ||
|
| beta (−log10 | beta (−log10 | beta (−log10 | ||||
| 1 | F8-T8--F7-T7 | 0.01 (1.55) | 0.01 (0.58) | 0.01 (0.70) | 0.01 (2.25) | (0.01)1.04 | 0.02 (4.12) |
| 2 | F4-C4--F3-C3 | 0.01 (1.09) | 0.02 (2.56) |
|
| 0.02 (3.77) |
|
| 3 | F3-C3--F8-T8 | 0.01 (1.56) | 0.00 (0.54) | 0.01 (1.98) | 0.01 (1.81) | 0.01 (1.43) |
|
| 4 | F4-C4--F7-T7 | 0.01 (0.73) | 0.01 (0.86) | 0.01 (1.87) | 0.02 (2.90) | 0.01 (1.08) | 0.02 (3.03) |
| 5 | F3-C3--F7-T7 | 0.01 (0.55) | 0.00 (0.64) |
|
| 0.02 (2.08) |
|
| 6 | F4-C4--F8-T8 | 0.01 (1.15) | 0.01 (1.18) | 0.01 (0.57) | 0.01 (0.89) | 0.02 (1.83) | 0.03 (3.73) |
| 7 | FZ-CZ--F7-T7 | 0.0 (0.36) | 0.01 (1.10) | 0.01 (2.11) |
| 0.01 (1.46) |
|
| 8 | FZ-CZ--F3-C3 | 0.02 (2.37) |
|
|
| 0.03 (3.48) |
|
| 9 | FZ-CZ--F8-T8 | 0.01 (1.14) | 0.01 (1.23) | 0.00 (0.26) | 0.01 (1.32) | 0.01 (0.81) | 0.02 (3.01) |
| 10 | FZ-CZ--F4-C4 | 0.01 (0.65) | 0.01 (1.34) | 0.03 (3.85) | 0.02 (2.82) |
|
|
|
| |||||||
| 11 | T8-P8--T7-P7 | 0.00 (0.88) | 0.01 (1.34) |
|
| 0.02 (6.33 *) |
|
| 12 | C4-P4--C3-P3 | 0.01 (0.79) | 0.02 (2.59) |
|
| 0.03 (5.46) |
|
| 13 | C3-P3--T8-P8 | 0.00 (0.60) | 0.02 (1.70) |
|
| 0.01 (2.49) |
|
| 14 | C4-P4--T7-P7 | 0.01 (1.19) | 0.02 (1.61) |
|
| 0.01 (3.54) |
|
| 15 | C3-P3--T7-P7 | 0.01 (0.73) | 0.01 (1.46) | 0.02 (2.10) |
| 0.01 (0.67) |
|
| 16 | C4-P4--T8-P8 | 0.01 (1.66) | 0.02 (2.25) |
|
| 0.02 (3.20) |
|
| 17 | T7-P7--CZ-PZ | 0.00 (0.57) | 0.01 (1.03) |
|
| 0.01 (3.42) |
|
| 18 | C3-P3--CZ-PZ | 0.02 (2.85) | 0.02 (2.56) |
|
|
|
|
| 19 | T8-P8--CZ-PZ | 0.01 (1.42) | 0.01 (1.47) |
|
| 0.01 (2.74) | 0.03 (3.61) |
| 20 | C4-P4--CZ-PZ | 0.01 (1.40) | 0.02 (1.70) |
|
|
| 0.03 (3.56) |
|
| |||||||
| 21 | P4-O2--P3-O1 | 0.02 (3.72) | 0.03 (3.20) |
|
|
|
|
|
| |||||||
| 22 | T7-C3--F7-F3 | 0.01 (0.99) | 0.01 (0.60) |
| 0.03 (3.76) |
| 0.02 (2.14) |
| 23 | P7-P3--F7-F3 | 0.00 (0.99) | 0.01 (1.14) |
|
| 0.02 (2.64) | 0.01 (1.61) |
| 24 | P7-P3--T7-C3 | 0.01 (1.76) | 0.03 (3.89) |
|
|
|
|
| 25 | T8-C4--F8-F4 | 0.00 (0.27) | 0.01 (1.15) | 0.03 (3.34) | 0.01 (1.09) |
| 0.03 (3.33) |
| 26 | P8-P4--F8-F4 | 0.00 (0.38) | 0.01 (1.68) | 0.01 (2.89) | 0.02 (3.57) | 0.01 (2.67) | 0.01 (2.37) |
| 27 | P8-P4--T8-C4 | 0.00 (0.72) | 0.02 (1.49) |
| 0.03 (3.17) |
| 0.03 (2.67) |
Note: *** p < 5 × 10−10; ** p < 5 × 10−8; * p < 5 × 10−6, p < 5× 10−4 are bolded.
Figure 2Association (−log10 p-value) of DSM-IV AD PRS (p < 0.001 threshold) at coherence pairs (y-axis) organized (top to bottom) from interhemispheric anterior pairs to posterior pairs, and intra-hemispheric pairs; prominent associations with fronto-central, tempo-parietal, centro-parietal, and parietal-occipital interhemispheric high alpha coherence are observed only among males from ages 18–31.
Association of AD PRS (p < 0.001) with neuropsychological performance and symptoms of DSM-5 alcohol, cannabis, cocaine, and opioid use disorder.
| DSM-IV AD PRS ( | ||
|---|---|---|
|
| Beta (Model 1) | Beta (Model 2) |
| TOLT Performance (number of optimal trials) | −0.097 ** | −0.027 * |
| TOLT Speed (average trial time) | 0.012 | 0.010 |
| VST Backwards Visual Span | 0.090 * | 0.040 * |
| VST Forwards Visual Span | −0.123 *** | −0.071 ** |
|
| ||
| DSM-5 Max Alcohol Use Disorder Symptom Count | 0.087 ** | 0.033 * |
| DSM-5 Max Cannabis Use Disorder Symptom Count | 0.043 | 0.023 |
| DSM-5 Max Cocaine Use Disorder Symptom Count | 0.037 | 0.017 |
| DSM-5 Max Opioid Use Disorder Symptom Count | 0.069 ** | 0.049 * |
*** p < 0.0001; ** p < 0.001; * p < 0.01; Model 1 covariates: age, sex, PCs1-3, genotype array; Model 2 covariates: age, sex, PCs, genotype array, maximum number of drinks consumed in a typical week (in the past 12 months).